Spironolactone Pre-Surgery Hold Window: What Clinicians and Patients Need to Know

At a glance

  • Surgery-related label use / short-term preoperative treatment of primary hyperaldosteronism, 100 to 400 mg daily [1]
  • Spironolactone half-life / about 1.4 hours [1]
  • Active metabolite half-lives / canrenone 16.5 h, TMS 13.8 h, HTMS 15 h [1]
  • Label monitoring rule / potassium within 1 week of starting or titrating, then regularly [1]
  • Drugs that add potassium risk / ACE inhibitors, ARBs, potassium supplements, salt substitutes, NSAIDs, heparin, trimethoprim [1]
  • Acne regimen in the SAFA trial / 50 mg daily for 6 weeks, then 100 mg daily to week 24 [2]

What the label says about surgery

The Aldactone label lists short-term preoperative treatment of primary hyperaldosteronism, at 100 to 400 mg daily in preparation for surgery [1]. For other uses it describes monitoring and dose limits. Hyperkalemia is a contraindication, and if it occurs the label says to decrease the dose or discontinue and treat [1].

How long does spironolactone stay active?

Spironolactone has a mean half-life of about 1.4 hours and peaks at 2.6 hours [1]. Its metabolites last longer: canrenone 16.5 hours, TMS 13.8 hours and HTMS 15 hours, with canrenone peaking at 4.3 hours [1]. The label does not translate these figures into a pre-surgery stop interval.

Which patients carry the highest potassium risk?

The label names impaired renal function, potassium supplements, potassium-containing salt substitutes, and potassium-raising drugs such as ACE inhibitors and angiotensin receptor blockers [1]. NSAIDs, heparin and low molecular weight heparin, and trimethoprim are also listed [1]. The label says to check serum potassium within a week of starting or titrating and regularly after that, with more frequent monitoring when other potassium-raising drugs are given or kidney function is impaired [1].

The label also warns that excessive diuresis may cause dehydration, hypotension and worsening renal function, particularly in salt-depleted patients or those taking ACE inhibitors or angiotensin II receptor blockers. It says NSAIDs, aminoglycosides and cisplatin can add to the risk of worsening renal function [1].

Acne doses and healthy patients

Acne is not a labeled use [1]. In the SAFA trial, 410 women with persistent facial acne took 50 mg daily for 6 weeks, then 100 mg daily to week 24, alongside usual topical treatment [2]. In a retrospective study of 974 healthy young women taking spironolactone for acne, 13 of 1,802 potassium measurements were abnormal (0.72%), compared with a 0.76% baseline rate in 1,165 comparison women. Six of the 13 abnormal values were normal on repeat [3]. That study excluded people with heart or kidney disease and those taking drugs that affect the renin-angiotensin system [3]. The Aldactone label itself still says to monitor potassium [1].

What matters on the day of a procedure

The label's warnings make a current potassium value and a complete medication and supplement list relevant, including potassium supplements, potassium-containing salt substitutes, ACE inhibitors, ARBs, NSAIDs, heparin and trimethoprim [1]. A general review of perioperative medication management says decisions about stopping or continuing a drug should weigh withdrawal potential, the risk of disease progression if treatment is interrupted, possible interactions with anesthesia, and short-term quality of life [4]. That review is not specific to spironolactone.

Frequently asked questions

How many days before surgery should spironolactone be stopped?
The Aldactone label does not name a stop date before surgery. It says that if hyperkalemia occurs, decrease the dose or discontinue and treat [1].
Does the label recommend a potassium check before a procedure?
The label does not mention procedures. It says to check serum potassium within 1 week of starting or titrating spironolactone and regularly after that, and more often with other potassium-raising drugs or impaired kidney function [1].
Do lower acne doses change the risk?
These studies do not show whether a lower acne dose changes surgical or potassium risk. The SAFA trial used 50 mg daily for 6 weeks, then 100 mg daily through week 24 [2]. In a retrospective study of healthy young women with acne, abnormal potassium occurred in 0.72% of measurements, similar to the 0.76% comparison rate; the study excluded people with heart or kidney disease and people taking renin-angiotensin-system drugs [3].
How long does spironolactone stay in the body?
Spironolactone itself has a mean half-life of about 1.4 hours, but its metabolites last longer: canrenone 16.5 hours, TMS 13.8 hours and HTMS 15 hours [1].

References

  1. U.S. National Library of Medicine, DailyMed. Aldactone (spironolactone) tablets, Pfizer prescribing information. Aldactone (spironolactone) tablets, Pfizer label
  2. Santer M, Lawrence M, Pyne S, Renz S, Stuart BL, Sach T, et al. Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT. Health Technol Assess. 2024. Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT
  3. Plovanich M, Weng QY, Mostaghimi A. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne. JAMA Dermatol. 2015;151(9):941-4. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne
  4. Whinney C. Perioperative medication management: general principles and practical applications. Cleve Clin J Med. 2009;76 Suppl 4:S126-32. Perioperative medication management: general principles and practical applications
Evidence overview for spironolactone acne: Spironolactone Pre-Surgery Hold Window: What Clinicians and Patients Need to Know